Effect of preoperative vitamin D on postoperative atrial fibrillation incidence after coronary artery bypass grafting.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Who Took Part

The study group was 246 patients.

By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.

This randomized controlled clinical trial was conducted on 246 CABG patients with vitamin D deficiency.

All patients were randomly divided into intervention and control groups including 123 cases for each group.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

The patients were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

All patients in the intervention group were assessed continuously for the occurrence of POAF during the recovery period.

What Was Measured

PubMed files the paper under topics including Atrial Fibrillation, Coronary Artery Bypass, Vitamin D, Incidence, Vitamin D Deficiency, Risk Factors and Dietary Supplements.

Author keywords: Coronary artery bypass grafting (CABG) and Postoperative atrial fibrillation (POAF).

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 246 patients.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (General thoracic and cardiovascular surgery), a journal based in Japan.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.